Literature DB >> 7779087

Cloning of rat and mouse P2Y purinoceptors.

Y Tokuyama1, M Hara, E M Jones, Z Fan, G I Bell.   

Abstract

The cellular responses to ATP are mediated by specific high-affinity receptors designated as P2 purinoceptors, five subclasses of which have been defined pharmacologically-P2X, P2Y, P2U, P2T, and P2Z. A cDNA clone encoding a rat P2Y purinoceptor was isolated from an insulinoma cDNA library. The 373-amino acid rat P2Y purinoceptor sequence has 85.7% and 37.8% identity with chicken P2Y and rat P2U purinoceptors, respectively. The sequence of the mouse P2Y purinoceptor was also determined and there was 97.1% amino acid identity with the corresponding rat sequence. RNA blotting studies showed that rat P2Y purinoceptor mRNA was expressed at variable levels in many tissues including heart, brain, spleen, lung, liver, skeletal muscle and kidney, although it was not detected in testis. The cloned rat P2Y purinoceptor was expressed in Xenopus laevis oocytes and possessed the properties expected for this receptor subtype.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7779087     DOI: 10.1006/bbrc.1995.1798

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  30 in total

1.  P2Y(1) purinoceptor-mediated Ca(2+) signaling and Ca(2+) wave propagation in dorsal spinal cord astrocytes.

Authors:  S R Fam; C J Gallagher; M W Salter
Journal:  J Neurosci       Date:  2000-04-15       Impact factor: 6.167

2.  P2Y purinoceptor activation mobilizes intracellular Ca2+ and induces a membrane current in rat intracardiac neurones.

Authors:  D M Liu; C Katnik; M Stafford; D J Adams
Journal:  J Physiol       Date:  2000-07-15       Impact factor: 5.182

3.  Inhibition of adenylyl cyclase by neuronal P2Y receptors.

Authors:  Ursula Unterberger; Eugenia Moskvina; Thomas Scholze; Michael Freissmuth; Stefan Boehm
Journal:  Br J Pharmacol       Date:  2002-02       Impact factor: 8.739

4.  Potentiation of capsaicin receptor activity by metabotropic ATP receptors as a possible mechanism for ATP-evoked pain and hyperalgesia.

Authors:  M Tominaga; M Wada; M Masu
Journal:  Proc Natl Acad Sci U S A       Date:  2001-05-22       Impact factor: 11.205

5.  P2Y6 receptor mediates colonic NaCl secretion via differential activation of cAMP-mediated transport.

Authors:  Michael Köttgen; Thomas Löffler; Christoph Jacobi; Roland Nitschke; Hermann Pavenstädt; Rainer Schreiber; Sebastian Frische; Søren Nielsen; Jens Leipziger
Journal:  J Clin Invest       Date:  2003-02       Impact factor: 14.808

6.  [32P]2-iodo-N6-methyl-(N)-methanocarba-2'-deoxyadenosine-3',5'-bisphosphate ([32P]MRS2500), a novel radioligand for quantification of native P2Y1 receptors.

Authors:  Dayle Houston; Michihiro Ohno; Robert A Nicholas; Kenneth A Jacobson; T Kendall Harden
Journal:  Br J Pharmacol       Date:  2006-03       Impact factor: 8.739

Review 7.  International Union of Pharmacology LVIII: update on the P2Y G protein-coupled nucleotide receptors: from molecular mechanisms and pathophysiology to therapy.

Authors:  Maria P Abbracchio; Geoffrey Burnstock; Jean-Marie Boeynaems; Eric A Barnard; José L Boyer; Charles Kennedy; Gillian E Knight; Marta Fumagalli; Christian Gachet; Kenneth A Jacobson; Gary A Weisman
Journal:  Pharmacol Rev       Date:  2006-09       Impact factor: 25.468

8.  Purinergic inhibition of Na⁺,K⁺,Cl⁻ cotransport in C11-MDCK cells: Role of stress-activated protein kinases.

Authors:  Olga A Akimova; Sebastien Taurin; Nickolai O Dulin; Sergei N Orlov
Journal:  Purinergic Signal       Date:  2007-06-30       Impact factor: 3.765

9.  Purinergic receptors in the endocrine and exocrine pancreas.

Authors:  I Novak
Journal:  Purinergic Signal       Date:  2007-12-11       Impact factor: 3.765

10.  Effects of P2Y1 receptor on glial fibrillary acidic protein and glial cell line-derived neurotrophic factor production of astrocytes under ischemic condition and the related signaling pathways.

Authors:  Jing-Jun Sun; Ying Liu; Zhu-Rong Ye
Journal:  Neurosci Bull       Date:  2008-08       Impact factor: 5.203

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.